S

SPEZIALE A.

Last name: SPEZIALE A.

2017 (v1)

Publication

Metadata-only

Canakinumab treatment for patients with active recurrent or chronic TNF receptor-associated periodic syndrome (TRAPS): An open-label, phase II study

Gattorno M. Obici L. Cattalini M.

Objective: To evaluate the efficacy of canakinumab, a high-affinity human monoclonal anti-interleukin-1β antibody, in inducing complete or almost complete responses in patients with active tumour necrosis factor receptor-associated periodic syndrome (TRAPS). Methods: Twenty patients (aged 7-78 years) with active recurrent or chronic TRAPS were...

Uploaded on: April 14, 2023